Skip to main content

Table 2 Cox univariate and multivariate analysis of RFS and BCSS in the consecutive cohort

From: Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer

 

        BCSS

        RFS

 

HR (95% CI)

p

HR (95% CI)

p

All patients (n = 252)

    

3 marker panel

       Univariate

       Univariate

  Signature A

1.00

 

1.00

 

  Signature B

16.36 (2.23 - 120.30)

0.006

3.33 (1.75 – 6.31)

<0.001

3 marker panel

       Multivariate*

       Multivariate*

  Signature A

1.00

 

1.00

 

  Signature B

6.38 (0.79 – 51.26)

0.082

1.46 (0.66 – 3.19)

0.348

  1. * Multivariate analysis included adjustment for tumour size (continuous), tumour grade, age at diagnosis (continuous), nodal, ER, PR, Her2 and Ki67 status.
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us